Skip to main content

Peer Review reports

From: Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study

Original Submission
17 Oct 2017 Submitted Original manuscript
28 Nov 2017 Author responded Author comments - Joshua David Wallach
6 Nov 2017 Reviewed Reviewer Report - Ludovic Trinquart
19 Nov 2017 Reviewed Reviewer Report - Anna Bettina Haidich
Resubmission - Version 2
28 Nov 2017 Submitted Manuscript version 2
19 Jan 2018 Author responded Author comments - Joshua David Wallach
15 Jan 2018 Reviewed Reviewer Report - Ludovic Trinquart
28 Dec 2017 Reviewed Reviewer Report - Anna Bettina Haidich
Resubmission - Version 3
19 Jan 2018 Submitted Manuscript version 3
24 Jan 2018 Reviewed Reviewer Report - Ludovic Trinquart
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
9 Feb 2018 Editorially accepted
21 Mar 2018 Article published 10.1186/s12916-018-1023-9

You can find further information about peer review here.

Back to article page
\